In the F3 generation, at 30 weeks, the diabetes incidence was doubled in the cohort fed A1 beta-casein compared to the A2 cohort (A1: 40% vs. A2: 20.7%) (Figure 1). The gene discussed is CSN2; the disease is diabetes mellitus.